Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1470, 2005-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Imatinib still cost effective for CML
Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. :
Access to resources
Recommend
Nilotinib effective in imatinib-resistant/intolerant CML
Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. :
Value of imatinib uncertain in CML
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 479, 2005-01 ,pp. :
Imatinib mesylate promising for CML
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :
Imatinib + intensive chemo effective for Ph+ ALL in kids
Inpharma, Vol. 1, Iss. 1618, 2007-01 ,pp. :